NEWS
Our Latest News
ARCHIMED acquires generative AI Diagnostics player Arkstone to support fight against infectious disease
Private equity healthcare specialist ARCHIMED acquired a majority stake in Arkstone Medical Solutions (Arkstone), a pioneer in infectious disease clinical guidance and antimicrobial stewardship based on machine learning (ML) and generative artificial intelligence (gen AI).
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
November
8,
2024
ARCHIMED acquires FIM Medical, a leader in the vision, audio & respiratory medical devices market
October
15,
2024
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
September
11,
2024
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
September
4,
2024
368